Authorised

Product identification

Medicine name:
Rabisin Glikoproteiny wirusa wścieklizny nie mniej niż 1IU Zawiesina do wstrzykiwań
Active substance:
  • Rabies virus, Inactivated
Target species:
  • Cattle
  • Sheep
  • Horse
  • Cat
  • Ferret
  • Dog
Route of administration:
  • Subcutaneous use
  • Intramuscular use

Product details

Active substance and strength:
  • Rabies virus, Inactivated
    1.00
    international unit(s)
    /
    1.00
    international unit(s)
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Subcutaneous use
    • Cattle
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
    • Horse
      • All relevant tissues
        0
        day
    • Cat
    • Ferret
      • All relevant tissues
        0
        day
    • Dog
  • Intramuscular use
    • Cattle
      • All relevant tissues
        0
        day
    • Sheep
      • All relevant tissues
        0
        day
    • Horse
      • All relevant tissues
        0
        day
    • Cat
    • Ferret
      • All relevant tissues
        0
        day
    • Dog
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI02X
Authorisation status:
  • Valid
Authorised in:
  • Poland
Available in:
  • Poland
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France SCS
Responsible authority:
  • Office For Registration Of Medicinal Products Medical Devices And Biocidal Products
Authorisation number:
  • 0537
Date of authorisation status change:

Documents

Labelling

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Package Leaflet

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Summary of Product Characteristics

This document does not exist in this language (English). You can find it in another language below.
Polish (PDF)
Published on: 4/02/2022

Source URL: https://medicines.health.europa.eu/veterinary/600000059549